
Hexagon Bio
Developing novel therapeutics by understanding the complex interplay of biological systems.
About
Hexagon Bio is a biotechnology company focused on developing new medicines by leveraging a deep understanding of biological pathways and interactions. They aim to create therapies for diseases with high unmet medical needs.
Similar companies
AI-driven diagnostics that convert medical images into actionable genomic insights for faster cancer treatment decisions.
Shares HealthTech, Genomics
Developing novel therapeutics targeting dysfunctional DNA packaging for diseases like cancer.
Shares Biotech, Drug Discovery
Developing novel therapeutics for rare genetic diseases with a focus on protein degradation.
Shares Biotech, Drug Discovery
Clinical-stage biotechnology company developing Antibody Oligonucleotide Conjugates (AOCs) for serious diseases.
Shares Biotech, Drug Discovery
Biotechnology company specializing in antibody discovery and development with integrated 'Idea to IND' solutions.
Shares Biotech, Drug Discovery
Biopharmaceutical company developing therapies for neurodegenerative diseases, focusing on crossing the blood-brain barrier.
Shares Biotech, HealthTech
Key facts
- Website
- hexagonbio.com
- Headquarters
- Menlo Park, United States
- Founded
- 2019
- Employees
- 70
- Total funding
- $100M (Series B)
- Business model
- B2B
Funding rounds
| Date | Round | Amount | Lead investors |
|---|---|---|---|
| 21 Sept 2021 | Series B | $75M | Arch Venture Partners |
| 18 Jun 2019 | Seed | $25M | Arch Venture Partners |
Tech stack
Detected on hexagonbio.com, last scanned 23 Sept 2026. Run your own scan
- Frontend
- jQuery
- SEO
- Yoast SEO
- CMS / Builders
- WordPress
- Email provider
- Google Workspace
Test your Ahrefs DR
The backlink strength of a domain, on the Ahrefs 0 to 100 scale. About a minute.
Frequently asked
Is Hexagon Bio trustworthy and reputable?
StartupHub's Data Trust & Reputation score for Hexagon Bio is 77 out of 100, a generally safe rating, based on site security posture, privacy practices, malware and phishing checks, and public reputation signals.
How much funding has Hexagon Bio raised?
Hexagon Bio has raised a total of $100M in funding. The most recent round on record is Series B.
How many employees does Hexagon Bio have?
Hexagon Bio has approximately 70 people on record.
SEC filings, insider activity, nonprofit links and pay benchmarks for Hexagon Bio:
Company details: from public sources. Funding: no announced round on file. Ownership: not yet claimed by the company. Scores: measured by named tools; each links to its method. Our rules

